Abstract
To establish whether multiple sclerosis (MS) patients, who have lost the therapeutic effect of interferon-beta (IFN-beta) owing to neutralizing antibodies (NAbs) and subsequently revert from a NAb-positive to a NAb-negative state under continued IFN-beta-1b therapy, regain clinical effect after reversion.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Multiple Sclerosis |
| Vol/bind | 14 |
| Udgave nummer | 6 |
| Sider (fra-til) | 837-42 |
| Antal sider | 6 |
| ISSN | 1352-4585 |
| DOI | |
| Status | Udgivet - 1 jul. 2008 |
| Udgivet eksternt | Ja |